Nuclear co-expression of p21 and p27 induced effective cell-cycle arrest in T24 cells treated with BCG
- 70 Downloads
A proposed mechanism underlying the effect of bacillus Calmette–Guérin (BCG) treatment for bladder cancer cells is as follows: BCG-induced crosslinking of cell-surface receptors results in the activation of signaling cascades, including cell-cycle regulators. However, the clinical significance of cell-cycle regulators such as p21 and p27 is controversial. Here we investigated the relationship between BCG exposure and p21 and p27. We used confocal laser microscopy to examine the expression levels of pKi67, p21 and p27 in T24 cells (derived from human urothelial carcinoma) exposed six times to BCG. We performed dual immunofluorescence staining methods for p21 and p27 and observed the localization of nuclear and cytoplasm expressions. We investigated the priority of p27 over p21 regarding nuclear expression by using p27 Stealth RNAi™ (p27-siRNA). With 2-h BCG exposure, the nuclear-expression level of p21 and p27 was highest, while pKi67 was lowest. The percentage of double nuclear-expression of p21 and p27 in BCG cells was significantly higher than that in control cells during the 1st to 6th exposure (P < 0.05), and the expression of pKi67 showed the opposite of this pattern. Approximately 10% of the nuclear p21 was independent of p27, whereas the cytoplasmic p21 was dependent on p27. Our results suggested that the nuclear co-expression of p21 and p27 caused effective cell-cycle arrest, and thus the evaluation of the nuclear co-expression of p21 and p27 might help determine the effectiveness of BCG treatment.
KeywordsBCG Cell-cycle arrest T24 cells Nuclear co-expression p27-siRNA
This study was supported by JSPS KAKENHI Grant Nos. #JP25460459 and #JP17K08744.
Compliance with ethical standards
Conflict of interest
The authors have no conflict of interest.
- Babjuk M, Böhle A, Burger M, Compérat E, Kaasinen E, Palou J, Rouprêt M, van Rhijn BWG, Shariat S, Sylvester R, Zigeuner R (2015) Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1 and CIS). https://uroweb.org/wp-content/uploads/EAU-Guidelines-Non-muscle-invasive-Bladder-Cancer-2015-v1.pdf. Accessed 8 Apr 2017
- Cooper MJ, Haluschak JJ, Johnson D, Schwartz S, Morrison LJ, Lippa M, Hatzivassiliou G, Tan J (1994) p53 mutations in bladder carcinoma cell lines. Oncol Res 6:569–579Google Scholar
- Cormio L, Tolve I, Annese P, Saracino A, Zamparese R, Sanguedolce F, Bufo P, Battaglia M, Selvaggi FP, Carrieri G (2009) Altered p53 and pRb expression is predictive of response to BCG treatment in T1G3 bladder cancer. Anticancer Res 29:4201–4204Google Scholar
- Sato M, Yanai H, Morito T, Oda W, Shin-no Y, Yamadori I, Tshushima T, Yoshino T (2011) Association between the expression pattern of p16, pRb and p53 and the response to intravesical bacillus Calmette–Guérin therapy in patients with urothelial carcinoma in situ of the urinary bladder. Pathol Int 61:456–460CrossRefGoogle Scholar
- van Rhijn BW, Vis AN, van der Kwast TH, Kirkels WJ, Radvanyi F, Ooms EC, Chopin DK, Boevé ER, Jöbsis AC, Zwarthoff EC (2003) Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome. J Clin Oncol 21:1912–1921CrossRefGoogle Scholar
- van Rhijn BW, Liu L, Vis AN, Bostrom PJ, Zuiverloon TCM, Fleshner NE, Aa MNM, Alkhateeb SS, Bangma CH, Jewett MAS, Zwarthoff EC, Bapat B, van der Kwast TH, Zlotta AR (2012) Prognostic value of molecular markers, substage and European Organisation for the Research and Treatment of Cancer risk scores in primary T1 bladder cancer. BJU Int 110:1169–1176CrossRefGoogle Scholar
- Zlotta AR, Noel JC, Fayt I, Drowart A, Van Vooren JP, Huygen K, Simon J, Schulman CC (1999) Correlation and prognostic significance of p53, p21WAF1/CAP1 and Ki-67 expression in patients with superficial bladder tumors treated with Bacillus Calmette–Guérin intravesical therapy. J Urol 161:792–798CrossRefGoogle Scholar